TABLE 1.
Patient demographics and baseline characteristics.
| Characteristic | Group | Value |
|---|---|---|
| Median age, years [range] | 57.0 [49.0, 64.0] | |
| Sex, n (%) | Male | 54 (78.3) |
| Female | 15 (21.7) | |
| HCC etiology, n (%) | HBV | 57 (82.6) |
| HCV | 3 (4.3) | |
| Alcohol | 3 (4.3) | |
| Unknown | 6 (8.6) | |
| ECOG PS, n (%) | 0 | 50 (72.5) |
| 1 | 19 (27.5) | |
| Number, n (%) | ≤3 | 51 (73.9) |
| >3 | 18 (26.1) | |
| Median size, cm [range] | 7.9 [5.2, 11.0] | |
| PVTT, n (%) | I | 9 (13.0) |
| II | 33 (47.8) | |
| III | 16 (23.2) | |
| IV | 11 (15.9) | |
| Metastastic sites, n (%) | 24 (34.8) | |
| Lung | 15 (21.7) | |
| Bone | 5 (7.2) | |
| Peritoneal | 2 (2.9) | |
| AFP, n (%) | < 400 ng/mL | 42 (60.9) |
| ≥400 ng/mL | 27 (39.1) | |
| Prior therapy, n (%) | Resection | 7 (10.1) |
| Ablation | 26 (37.7) | |
| ALBI, n (%) | 1 | 11 (15.9) |
| 2 | 52 (75.4) | |
| 3 | 6 (8.7) | |
| Child‐Pugh grade, n (%) | A | 42 (60.9) |
| B | 27 (39.1) |
Abbreviations: AFP, alpha‐fetoprotein; ALBI, albumin‐bilirubin grade; ECOG PS, Eastern Cooperative Oncology Group performance status; HBV, hepatitis B virus; HCC, hepatocelluar carcinoma; HCV, hepatitis C virus; PVTT, portal vein tumor thrombosis.